Sign inJoin waitlistJoin the waitlist

Mark Schroeder

Physician · Washington University School of Medicine

Credentials: · · · · ·

History

Washington University School of Medicine
Present

Hematology and Medical Oncology
2006–2009
Internal Medicine
2003–2006
University of Cincinnati College of Medicine
1999–2003

Research

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
New England Journal of Medicine · 2016 · 716 citations
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Neuro-Oncology · 2009 · 327 citations
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
Neuro-Oncology · 2005 · 279 citations

John DiPersio
51 papers
Ravi Vij
45 papers
Keith Stockerl-Goldstein
37 papers
PW
Peter Westervelt
35 papers
Geoffrey Uy
30 papers
Camille Abboud
28 papers
Jann Sarkaria
28 papers
Amanda Cashen
23 papers
Rizwan Romee
22 papers
IP
Iskra Pusic
20 papers
AG
Armin Ghobadi
17 papers · 5 as a fellow
MS
Michael Slade
16 papers · 9 as a resident

Clinical trials

Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
Principal investigator · Recruiting · Phase 1
Washington University School of Medicine
2026–2031
ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
2020–2022
Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2020–2022
Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
Principal investigator · Completed · Phase 2
Masonic Cancer Center, University of Minnesota
2020–2022